The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1
Open accessAbstract
Glucocorticoids (GCs), which are used in the treatment of immune-mediated inflammatory diseases, inhibit the expression of many inflammatory mediators. They can also induce the expression of dual specificity phosphatase 1 (DUSP1; otherwise known as mitogen-activated protein kinase [MAPK] phosphatase 1), which dephosphorylates and inactivates MAPKs. We investigated the role of DUSP1 in the antiinflammatory action of the GC dexamethasone (Dex). Dex-mediated inhibition of c-Jun N-terminal kinase and p38 MAPK was abrogated in DUSP1-/- mouse macrophages. Dex-mediated suppression of several proinflammatory genes (including tumor necrosis factor, cyclooxygenase 2, and interleukin 1alpha and 1beta) was impaired in DUSP1-/- mouse macrophages, whereas other proinflammatory genes were inhibited by Dex in a DUSP1-independent manner. In vivo antiinflammatory effects of Dex on zymosan-induced inflammation were impaired in DUSP1-/- mice. Therefore, the expression of DUSP1 is required for the inhibition of proinflammatory signaling pathways by Dex in mouse macrophages. Furthermore, DUSP1 contributes to the antiinflammatory effects of Dex in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GR-mediated transactivation typically induces the expression of potent signaling inhibitors (e.g., IκBα, MPK-1, IL-10, Annexin A1, GILZ, and SOCS proteins), which strongly interfere with salient immune signaling pathways such as those triggered by the Toll-like receptors (TLR) (82–85).”
From The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain (2014) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068
Self-citationDual specificity phosphatases: a gene family for control of MAP kinase function
Camps, M., NICHOLS, A., & Arkinstall, S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.6 · Cited by 823
Possible new role for NF-κB in the resolution of inflammation
Lawrence, T., Gilroy, D. W., Colville‐Nash, P., & Willoughby, D. A. (2001) · Nature Medicine · doi:10.1038/nm1201-1291 · Cited by 753
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
Chi, H., Barry, S. P., Flach, R. J. R., Wu, J. J., Jones, E. A., Bennett, A. M., & Flavell, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510965103 · Cited by 568
Molecular mechanisms of glucocorticoid action: what is important?
Newton, R. C. (2000) · Thorax · doi:10.1136/thorax.55.7.603 · Cited by 507
Swantek, J. L., Cobb, M. H., & Geppert, T. D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6274 · Cited by 491
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
Reichardt, H. M., Tuckermann, J. P., Göttlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., & Schütz, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7168 · Cited by 429
MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock
Zhao, Q., Wang, X., Nelin, L. D., Yao, Y., Matta, R., Manson, M. E., Baliga, R. S., Meng, X., Smith, C. V., Bauer, J. A., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051794 · Cited by 370
Essential Role of MAPK Phosphatase-1 in the Negative Control of Innate Immune Responses
Salojin, K. V., Owusu, I. B., Millerchip, K. A., Potter, M. D., Platt, K. A., & Oravecz, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1899 · Cited by 333
Flagged first, then by citations
Research works printed but not linked: 3
- 2005, Curr. Opin. Investig. Drugs., 6, 503
- 1996, Oncogene., 13, 925
- 2002, FASEB J., 16, 1832
Cited by
Sorted by citations
Items 101–200 of 430
Kelly, M., King, E., Rider, C. F., Gwozd, C., Holden, N. S., Eddleston, J., Zuraw, B. L., Leigh, R., O’Byrne, P. M., & Newton, R. C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01620.x · Cited by 81
Maier, J. V., Brema, S., Tuckermann, J. P., Herzer, U., Klein, M., Stassen, M., Moorthy, A., & Cato, A. C. B. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0067 · Cited by 80
Ramesh, G., Benge, S., Pahar, B., & Philipp, M. T. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-72 · Cited by 80
Preković, S., Schuurman, K. G., Mayayo‐Peralta, I., Manjón, A. G., Buijs, M., Yavuz, S., Wellenstein, M. D., Barrera, A., Monkhorst, K., Huber, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24537-3 · Cited by 87
Acetylation of MKP-1 and the Control of Inflammation
Chi, H., & Flavell, R. A. (2008) · Science Signaling · doi:10.1126/scisignal.141pe44 · Cited by 80
Tan, Y., Zhang, X., & Cheang, W. S. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00653-0 · Cited by 78
Ishmael, F. T., Fang, X., Houser, K. R., Pearce, K. H., Abdelmohsen, K., Zhan, M., Gorospe, M., & Stellato, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001794 · Cited by 80
Smallie, T., Ross, E. A., Ammit, A. J., Cunliffe, H. E., Tang, T., Rosner, D. R., Ridley, M. L., Buckley, C. D., Saklatvala, J., Dean, J. L. E., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402830 · Cited by 76
Mancini, A. D., & Battista, J. A. D. (2011) · Inflammation Research · doi:10.1007/s00011-011-0385-7 · Cited by 75
Salojin, K. V., & Oravecz, T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1006639 · Cited by 76
Glucocorticoid Regulation of Mouse and Human Dual Specificity Phosphatase 1 (DUSP1) Genes
Tchen, C. R., Martins, J. R. S., Paktiawal, N., Perelli, R., Saklatvala, J., & Clark, A. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.037309 · Cited by 75
Gerber, A. N., Newton, R. C., & Sasse, S. K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100687 · Cited by 75
Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Pidala, J., & Anasetti, C. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.01.007 · Cited by 74
James, C. G., Ulici, V., Tuckermann, J. P., Underhill, T. M., & Beier, F. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-205 · Cited by 72
Mitogen‐Activated Protein Kinase Phosphatase 1 as an Inflammatory Factor and Drug Target
Korhonen, R., & Moilanen, E. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12141 · Cited by 73
Dutra-Medeiros, M., Alkabes, M., Navarro, R., García‐Arumí, J., Mateo, C., & Corcóstegui, B. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2014.0010 · Cited by 70
Sevilla, L. M., Jiménez‐Panizo, A., Alegre‐Martí, A., Estébanez‐Perpiñá, E., Caelles, C., & Pérez, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810049 · Cited by 78
Crosstalk between p38 MAPK and GR Signaling
Zeyen, L., Seternes, O. M., & Mikkola, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063322 · Cited by 70
Effects of Glucocorticoids on Apoptosis and Clearance of Apoptotic Cells
McColl, A., Michlewska, S., Dransfield, I., & Rossi, A. G. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.224 · Cited by 69
Mechanisms of TNFα regulation in uveitis: Focus on RNA-binding proteins
Khera, T. K., Dick, A. D., & Nicholson, L. B. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.08.003 · Cited by 67
Gräb, J., Suárez, I., van Gumpel, E., Winter, S., Schreiber, F., Esser, A., Hölscher, C., Fritsch, M., Herb, M., Schramm, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08405-9 · Cited by 69
Wright, M. M., Kim, J.-H., Hock, T., Leitinger, N., Freeman, B. Α., & Agarwal, A. (2009) · Biochemical Journal · doi:10.1042/bj20090339 · Cited by 66
p38 MAPK Signaling in Oral-related Diseases
Patil, C. S., & Kirkwood, K. L. (2007) · Journal of Dental Research · doi:10.1177/154405910708600903 · Cited by 66
Horsch, K., de Wet, H., Schuurmans, M. M., Allie-Reid, F., Cato, A. C. B., Cunningham, J., Burrin, J. M., Hough, F. S., & Hulley, P. A. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0153 · Cited by 65
Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene?
Mayayo-Peralta, I., Zwart, W., & Preković, S. (2021) · Endocrine-Related Cancer · doi:10.1530/erc-20-0489 · Cited by 53
Tumor Necrosis Factor Inhibits Glucocorticoid Receptor Function in Mice
Bogaert, T. V., Vandevyver, S., Dejager, L., Hauwermeiren, F. V., Pinheiro, I., Πέττα, Ι., Engblom, D., Kleyman, A., Schütz, G., Tuckermann, J. P., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212365 · Cited by 66
Mechanisms of glucocorticoid action and insensitivity in airways disease
Boardman, C., Chachi, L., Gavrila, A., Keenan, C. R., Perry, M. M., Xia, Y., Meurs, H., & Sharma, P. K. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.08.008 · Cited by 69
It takes two to tango: Dimerisation of glucocorticoid receptor and its anti-inflammatory functions
Nixon, M., Andrew, R., & Chapman, K. E. (2012) · Steroids · doi:10.1016/j.steroids.2012.09.013 · Cited by 62
Wang, X., Nelin, L. D., Kuhlman, J. R., Meng, X., Welty, S. E., & Liu, Y. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.09.003 · Cited by 61
Molecular mechanisms of glucocorticoid action in mast cells
Oppong, E. K., Flink, N., & Cato, A. C. B. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.05.014 · Cited by 62
Zhao, Y., Shen, X., Cao, K., Ding, J., Kang, X., Guan, W.-X., Ding, Y.-T., Liu, B.-R., & Du, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00282 · Cited by 61
Modulation of LPS-Stimulated Pulmonary Inflammation by Borneol in Murine Acute Lung Injury Model
Zhong, W., Cui, Y., Yu, Q., Xie, X., Liu, Y., Wei, M., Ci, X., & Peng, L. (2014) · Inflammation · doi:10.1007/s10753-014-9839-8 · Cited by 60
Nieminen, R. M., Korhonen, R., Moilanen, T. P. S., Clark, A. R., & Moilanen, E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27409 · Cited by 60
Post-transcriptional gene regulation by MAP kinases via AU-rich elements
Clark, A. R. (2009) · Frontiers in bioscience · doi:10.2741/3282 · Cited by 59
The neuroendocrine control of the innate immune system in health and brain diseases
Bellavance, M., & Rivest, S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01129.x · Cited by 61
Glucocorticoid-Induced Leucine Zipper: A Critical Factor in Macrophage Endotoxin Tolerance
Hoppstädter, J., Kessler, S. M., Bruscoli, S., Huwer, H., Riccardi, C., & Kiemer, A. K. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403207 · Cited by 59
Rastogi, R., Jiang, Z., Ahmad, N., Rosati, R., Liu, Y., Beuret, L., Monks, R., Charron, J., Birnbaum, M. J., & Samavati, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.492702 · Cited by 59
Newton, R. C., & Giembycz, M. A. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13628 · Cited by 62
Diefenbacher, M. E., Sekula, S., Heilbock, C., Maier, J. V., Litfin, M., van Dam, H., Castellazzi, M., Herrlich, P. A., & Kassel, O. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0574 · Cited by 57
Stellato, C. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.10.041 · Cited by 58
Manetsch, M., Che, W., Seidel, P., Chen, Y., & Ammit, A. J. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.013 · Cited by 56
Bechah, Y., Paddock, C. D., Capo, C., Mège, J., & Raoult, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008547 · Cited by 57
Therapeutic PCL scaffold for reparation of resected osteosarcoma defect
Palamà, I. E., Arcadio, V., D’Amone, S., Biasiucci, M., Gigli, G., & Cortese, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-12824-3 · Cited by 57
p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics
Ahmadi, A., Ahrari, S., Salimian, J., Salehi, Z., Karimi, M., Emamvirdizadeh, A., Jamalkandi, S. A., & Ghanei, M. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01337-4 · Cited by 59
The glucocorticoid receptor in inflammatory processes: transrepression is not enough
Hübner, S., Dejager, L., Libert, C., & Tuckermann, J. P. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0106 · Cited by 57
Liao, J., Wang, X., Bi, Y., Shen, B., Shao, K., Yang, H., Lu, Y., Zhang, Z., Chen, X., Liu, H., et al. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.2hi1113-611rr · Cited by 56
Role of Transcription Factors in the Pathogenesis of Asthma and COPD
Caramori, G., Casolari, P., & Adcock, I. M. (2013) · Cell Communication & Adhesion · doi:10.3109/15419061.2013.775257 · Cited by 57
Pietras, T., Panek, M., Tworek, D., Oszajca, K., Wujcik, R., Górski, P., Kuna, P., & Szemraj, J. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0512-5 · Cited by 55
Kim, H. S., & Asmis, R. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.020 · Cited by 54
Leiro, V., Santos, S. D., Lopes, C. D. F., & Pêgo, A. P. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201700313 · Cited by 56
Optimization of Dexamethasone Mixed Nanomicellar Formulation
Cholkar, K., Hariharan, S., Gunda, S., & Mitra, A. K. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0159-y · Cited by 55
Mavropoulos, Α., Orfanidou, T., Liaskos, C., Smyk, D. S., Billinis, C., Blank, M., Rigopoulou, E. I., & Bogdanos, D. P. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.10.019 · Cited by 55
Zimmermann, G. R., Avery, W., Finelli, A. L., Farwell, M., Fraser, C. C., & Borisy, A. A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2602 · Cited by 54
Dutra-Medeiros, M., Navarro, R., García‐Arumí, J., Mateo, C., & Corcóstegui, B. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11463 · Cited by 53
Dusp5 negatively regulates IL‐33‐mediated eosinophil survival and function
Holmes, D. A., Yeh, J.-H., Yan, D., Xu, M., & Chan, A. C. (2014) · The EMBO Journal · doi:10.15252/embj.201489456 · Cited by 57
Cavet, M. E., Harrington, K. L., Ward, K. W., & Zhang, J.-Z. (2010) · PubMed Central · Cited by 54
Bhattacharyya, S., Ratajczak, C. K., Vogt, S. K., Kelley, C., Colonna, M., Schreiber, R. D., & Muglia, L. J. (2010) · Blood · doi:10.1182/blood-2009-06-224782 · Cited by 53
5α-Reduced glucocorticoids: a story of natural selection
Nixon, M., Upreti, R., & Andrew, R. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0318 · Cited by 56
Johansson-Haque, K., Palanichamy, E., & Okret, S. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0015 · Cited by 53
Joanny, E., Ding, Q., Gong, L., Kong, P. L., Saklatvala, J., & Clark, A. R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01574.x · Cited by 53
Landry, R. P., Martinez, E., DeLeo, J. A., & Romero-Sandoval, E. A. (2012) · Journal of Pain · doi:10.1016/j.jpain.2012.05.013 · Cited by 51
Bertin, S., Lozano‐Ruiz, B., Bachiller, V., García‐Martinez, I., Herdman, S., Zapater, P., Francés, R., Such, J. M., Lee, J., Raz, E., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.84 · Cited by 51
Persistence of Coxiella burnetii, the Agent of Q Fever, in Murine Adipose Tissue
Bechah, Y., Verneau, J., Amara, A. B., Barry, A. O., Lépolard, C., Achard, V., Panicot‐Dubois, L., Textoris, J., Capo, C., Ghigo, É., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097503 · Cited by 51
Korhonen, R., Hömmö, T., Keränen, T., Laavola, M., Hämäläinen, M., Vuolteenaho, K., Lehtimäki, L. A., Kankaanranta, H., & Moilanen, E. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12189 · Cited by 51
Newton, R. C., King, E. M., Gong, W., Rider, C. F., Staples, K. J., Holden, N. S., & Bergmann, M. W. (2010) · Biochemical Journal · doi:10.1042/bj20091038 · Cited by 50
Zhang, J. Z., Cavet, M. E., VanDerMeid, K. R., Salvador‐Silva, M., López, F. J., & Ward, K. W. (2009) · PubMed Central · Cited by 50
Chuang, Y., Yang, H., Ko, T.-L., Hsu, Y.-F., Sheu, J., Ou, G., & Hsu, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.02.004 · Cited by 51
Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients
Goleva, E., Jackson, L. P., Gleason, M. C., & Leung, D. Y. M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.12.001 · Cited by 49
Daull, P., Paterson, C. A., Kuppermann, B. D., & Garrigue, J. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0044 · Cited by 48
Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes
Sawmynaden, P., & Perretti, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.179 · Cited by 51
Denans, N., Tran, N. T. T., Swall, M. E., Diaz, D. C., Blanck, J. F., & Piotrowski, T. (2022) · Nature Communications · doi:10.1038/s41467-022-33015-3 · Cited by 50
MAPK phosphatases as novel targets for rheumatoid arthritis
Ralph, J. A., & Morand, E. F. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.7.795 · Cited by 48
MAP kinase phosphatase-1, a gatekeeper of the acute innate immune response
Kirk, S. G., Samavati, L., & Liu, Y. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117157 · Cited by 47
Vollmer, T. R., Stockhausen, A., & Zhang, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.400671 · Cited by 46
Lu, T.-C., Wang, Z., Feng, X., Chuang, P. Y., Fang, W. Y., Chen, Y., Neves, S. R., Ma’ayan, A., Xiong, H., Liu, Y., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00245-08 · Cited by 45
Challenges to develop novel anti‐inflammatory and analgesic drugs
Botz, B., Bölcskei, K., & Helyes, Z. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1427 · Cited by 44
Gene Expression Profiles Identify Inflammatory Signatures in Dendritic Cells
Torri, A., Beretta, O., Ranghetti, A., Granucci, F., Ricciardi‐Castagnoli, P., & Foti, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009404 · Cited by 43
Yao, C., Wang, Y., Zhang, H., Feng, W., Wang, Q., Shen, D., Qian, T., Liu, F., Mao, S., Gu, X., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3790-16.2018 · Cited by 42
Vattakuzhi, Y., Abraham, S., Freidin, A. J., Clark, A. R., & Horwood, N. J. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34403 · Cited by 43
Kang, B. N., Jude, J. A., Panettieri, R. A., Walseth, T. F., & Kannan, M. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00352.2007 · Cited by 43
Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids
Li, F., Zhang, M.-J., Hussain, F., Triantaphyllopoulos, K. A., Clark, A. R., Bhavsar, P. K., Zhou, X., & Chung, K. F. (2010) · European Respiratory Journal · doi:10.1183/09031936.00021110 · Cited by 41
Zakkar, M., Luong, L. A., Chaudhury, H., Ruud, O., Punjabi, P. P., Anderson, J. R., Mulholland, J. W., Clements, A. T., Krams, R., Foin, N., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.979542 · Cited by 41
Overcoming Reduced Glucocorticoid Sensitivity in Airway Disease
Marwick, J. A., Adcock, I. M., & Chung, K. F. (2010) · Drugs · doi:10.2165/10898520-000000000-00000 · Cited by 40
Turpeinen, T., Nieminen, R. M., Moilanen, E., & Korhonen, R. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157438 · Cited by 42
Anti-Inflammatory Effects of β2-Receptor Agonists Salbutamol and Terbutaline Are Mediated by MKP-1
Keränen, T., Hömmö, T., Hämäläinen, M., Moilanen, E., & Korhonen, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148144 · Cited by 40
Progesterone and the Repression of Myometrial Inflammation: The Roles of MKP-1 and the AP-1 System
Lei, K., Georgiou, E. X., Chen, L., Yulia, A., Sooranna, S. R., Brosens, J. J., Bennett, P. R., & Johnson, M. R. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1122 · Cited by 39
Recent Advances in Anti-inflammatory Strategies for Implantable Biosensors and Medical Implants
Lee, D., Park, K., & Seo, J. (2020) · BioChip Journal · doi:10.1007/s13206-020-4105-7 · Cited by 38
Zhang, Z., Dong, L., Jia, A., Chen, X., Yang, Q., Wang, Y., Wang, Y., Liu, R., Cao, Y., He, Y., et al. (2020) · Cancers · doi:10.3390/cancers12040945 · Cited by 38
c-Jun N-terminal kinases as potential therapeutic targets
Salh, B. S. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.10.1339 · Cited by 38
Feng, B., He, Q., & Xu, H. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.001 · Cited by 37
Mager, C. E., Mormol, J. M., Shelton, E. D., Murphy, P. R., Bowman, B. A., Barley, T. J., Wang, X., Linn, S. C., Liu, K., Nelin, L. D., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.103043 · Cited by 36
Cho, I. J., & Kim, S. G. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0257 · Cited by 35
Peng, H.-Z., Yun, Z., Wang, W., & Ma, B. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7617 · Cited by 37
Rare variant analysis in eczema identifies exonic variants in DUSP1, NOTCH4 and SLC9A4
Grosche, S., Marenholz, I., Esparza-Gordillo, J., Arnau‐Soler, A., Pairo‐Castineira, E., Rüschendorf, F., Ahluwalia, T. S., Almqvist, C., Arnold, A., Baurecht, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26783-x · Cited by 36
Korhonen, R., Turpeinen, T., Taimi, V., Nieminen, R. M., Goulas, A., & Moilanen, E. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.06.439 · Cited by 36
Wolf, J., Boneva, S., Rosmus, D.-D., Agostini, H. T., Schlunck, G., Wieghofer, P., Schlecht, A., & Lange, C. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.3.9 · Cited by 36
Liang, L., Li, F., Bao, A., Zhang, M., Chung, K. F., & Zhou, X. (2013) · Respirology · doi:10.1111/resp.12189 · Cited by 35
BinMahfouz, H., Borthakur, B., Yan, D., George, T., Giembycz, M. A., & Newton, R. C. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.093393 · Cited by 35
Kobayashi, S., Stice, J. P., Kazmin, D. A., Wittmann, B. M., Kimbrel, E. A., Edwards, D. P., Chang, C., & McDonnell, D. P. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0289 · Cited by 35
Interaction and Functional Interference of Glucocorticoid Receptor and SOCS1
Haffner, M. C., Jurgeit, A., Berlato, C., Geley, S., Parajuli, N., Yoshimura, A., & Doppler, W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801041200 · Cited by 37
Metadata
- Authors
- Abraham, S. M., Lawrence, T., Kleiman, A., Warden, P., Medghalchi, M., Tuckermann, J., Saklatvala, J., & Clark, A. R.
- Affiliations
- Imperial College London (GB)
- Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-07-31
- Volume
- 203
- Issue
- 8
- Pages
- 1883-1889
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118371
- OpenAlex
- W2159379486
- Cited by
- 430
- References
- 29
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 12 · 2023: 22 · 2022: 12 · 2021: 19 · 2020: 12 · 2019: 17 · 2018: 13 · 2017: 21 · 2016: 23 · 2015: 24 · 2014: 33 · 2013: 27 · 2012: 28
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- dexamethasone, glucocorticoids, MKP-1, MAPK phosphatase, macrophages, c-Jun N-terminal kinase, p38 MAPK, pro-inflammatory gene expression, TNF-α, cyclooxygenase-2, interleukin-1, zymosan-induced inflammation, MAPK dephosphorylation
- MeSH terms
- Animals, Anti-Inflammatory Agents, Bone Marrow, Dexamethasone, Dose-Response Relationship, Drug, Enzyme Induction, Gene Expression Regulation, Glucocorticoids, Inflammation, Macrophages, Phosphoprotein Phosphatases, RNA, Messenger, Signal Transduction, Protein Tyrosine Phosphatases, Immediate-Early Proteins, Cell Cycle Proteins, JNK Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Mice, Dual Specificity Phosphatase 1, Protein Phosphatase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
